Veterinary Medicines

Vominil 10 mg/ml Injektionslösung für Hunde und Katzen

Authorised
  • Maropitant citrate monohydrate
Download as PDF

Product identification

Medicine name:
Vominil 10 mg/ml Injektionslösung für Hunde und Katzen
Vominil 10 mg/ml Solution injectable pour chiens et chats
Vominil 10 mg/ml Oplossing voor injectie voor honden en katten
Vominil 10 mg/ml Injektionslösung für Hunde und Katzen
Active substance:
  • Maropitant citrate monohydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Maropitant citrate monohydrate
    14.48
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA04AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Amber glass vial type I (Ph. Eur.) with 10 ml solution for injection, closed with a chlorobutyl rubber stopper, type I (Ph. Eur) and aluminium pull or flip off cap in a cardboard box.
  • Amber glass vial type I (Ph. Eur.) with 25 ml solution for injection, closed with a chlorobutyl rubber stopper, type I (Ph. Eur) and aluminium pull or flip off cap in a cardboard box.
  • Amber glass vial type I (Ph. Eur.) with 50 ml solution for injection, closed with a chlorobutyl rubber stopper, type I (Ph. Eur) and aluminium pull or flip off cap in a cardboard box.
  • 5 x Amber glass vials type I (Ph. Eur.) with 10 ml solution for injection, closed with a chlorobutyl rubber stopper, type I (Ph. Eur) and aluminium pull or flip off cap in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetviva Richter GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V661759
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0030/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 12/10/2023
Download
French (PDF)
Published on: 12/10/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 12/10/2023
Download
French (PDF)
Published on: 12/10/2023
Download
German (PDF)
Published on: 12/10/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 12/10/2023
Download
French (PDF)
Published on: 12/10/2023
Download
German (PDF)
Published on: 12/10/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."